heparin

简明释义

英[ˈhepərɪn]美[ˈhepərɪn]

n. [生化] 肝素（用于防治血栓形成等）；肝磷脂

英英释义

单词用法

同义词

反义词

例句

1.Heparin sold in Germany by Rotexmedica GmbH, a unit of the French company Groupe Panpharma, also has been recalled.

此外，法国公司GroupePanpharma的子公司RotexmedicaGmbH在德国销售的肝素也被召回。

2.The heparin plant in China has not been accused of providing a harmful product.

中国的肝磷脂工厂没有被指责提供有害的产品。

3.Objective To investigate the pathogenesis of osteoporosis induced by heparin.

目的探讨肝素诱发骨质疏松症的发病机理。

4.However, heparin was not essential for the expression of the biological activity of FGF.

然而，为FGF的生物学的活动的表情肝磷脂不是本质的。

5.The FDA has received reports of hundreds of reactions and 19 deaths of patients after taking heparin.

此前FDA共接到因使用肝素而引起上百起不良反应和19起患者死亡报告。

6.Methods Erythrocyte sedimentation rate of 79 normal controls and 36 patients was determined with sodium citrate and heparin.

采用枸橼酸钠和肝素两种抗凝剂，对79例正常人和36例病人的红细胞沉降率进行了测定。

7.The doctor prescribed heparin to prevent blood clots after surgery.

医生开了肝素以防止手术后的血栓形成。

8.Patients receiving heparin must be monitored for signs of bleeding.

接受肝素治疗的患者必须监测出血迹象。

9.The nurse administered heparin via injection in the hospital.

护士在医院通过注射给药了肝素。

10.In cases of deep vein thrombosis, heparin is often used as a treatment.

在深静脉血栓的情况下，通常使用肝素作为治疗。

11.It is important to adjust the dosage of heparin based on the patient's weight.

根据患者体重调整肝素的剂量非常重要。

作文

Heparin is a naturally occurring anticoagulant that plays a crucial role in preventing blood clots. It is commonly used in medical settings, particularly during surgeries and in patients with conditions that increase the risk of thrombosis. The discovery of heparin has significantly advanced the field of medicine, offering a reliable means to manage blood coagulation. Heparin works by inhibiting specific factors in the blood clotting process, thus prolonging the time it takes for blood to clot. This is particularly important in situations where the risk of clot formation is heightened, such as during long surgeries or in patients who are immobile for extended periods. In addition to its use in surgical procedures, heparin is also administered to patients with deep vein thrombosis (DVT) and pulmonary embolism (PE). These conditions can be life-threatening if not treated promptly. By administering heparin, healthcare providers can reduce the risk of further clot formation and allow the body to dissolve existing clots more effectively. This is especially critical in emergency situations where rapid intervention is necessary. The effectiveness of heparin is often monitored through blood tests that measure the activated partial thromboplastin time (aPTT). This test helps ensure that the patient is receiving the correct dosage, as too much heparin can lead to excessive bleeding, while too little may not provide adequate protection against clotting. Therefore, careful management and monitoring are essential when using heparin in clinical practice. Despite its benefits, the use of heparin is not without risks. Some patients may develop heparin-induced thrombocytopenia (HIT), a serious condition where the body forms antibodies against heparin, leading to a paradoxical increase in clotting. This condition requires immediate medical attention and often necessitates the discontinuation of heparin therapy. In recent years, alternatives to heparin have been developed, such as low molecular weight heparins (LMWH) and direct oral anticoagulants (DOACs). These alternatives offer similar anticoagulant effects with potentially fewer side effects and a more predictable response. However, heparin remains a cornerstone in the management of anticoagulation therapy, especially in hospital settings. In conclusion, heparin is an invaluable medication in modern medicine, particularly in the prevention and treatment of thromboembolic disorders. Its ability to effectively manage blood clotting makes it essential in various medical scenarios, from routine surgeries to critical care. As research continues to evolve, understanding the mechanisms, benefits, and risks associated with heparin will be vital for healthcare professionals. Continued education and awareness about heparin and its applications can lead to improved patient outcomes and safer medical practices.

肝素是一种自然产生的抗凝剂，在防止血块形成方面发挥着至关重要的作用。它通常在医疗环境中使用，尤其是在手术期间和那些增加血栓风险的患者中。肝素的发现显著推动了医学领域的发展，为管理血液凝固提供了一种可靠的方法。肝素通过抑制血液凝固过程中的特定因子，从而延长血液凝固所需的时间。这在血栓形成风险加大的情况下尤为重要，例如在长时间的手术过程中或在长时间不动的患者中。 除了在手术程序中的应用，肝素还用于治疗深静脉血栓（DVT）和肺栓塞（PE）的患者。这些情况如果不及时治疗可能会危及生命。通过施用肝素，医疗提供者可以降低进一步形成血块的风险，并使身体更有效地溶解现有的血块。这在需要迅速干预的紧急情况下尤其关键。 肝素的有效性通常通过测量活化部分凝血酶时间（aPTT）的血液检测来监测。这项测试有助于确保患者接受正确的剂量，因为过多的肝素可能导致过度出血，而过少则可能无法提供足够的抗凝保护。因此，在临床实践中使用肝素时，仔细管理和监测至关重要。 尽管肝素具有许多好处，但其使用并非没有风险。一些患者可能会发展出肝素诱导的血小板减少症（HIT），这是一种严重的情况，身体对肝素产生抗体，导致血液凝固的反常增加。这种情况需要立即的医疗关注，通常需要停止肝素治疗。 近年来，已经开发出替代肝素的药物，例如低分子量肝素（LMWH）和直接口服抗凝剂（DOACs）。这些替代药物提供类似的抗凝效果，同时可能具有更少的副作用和更可预测的反应。然而，肝素仍然是抗凝治疗管理中的基石，尤其是在医院环境中。 总之，肝素在现代医学中是一种无价的药物，特别是在预防和治疗血栓性疾病方面。它有效管理血液凝固的能力使其在各种医疗场景中至关重要，从常规手术到重症护理。随着研究的不断发展，理解与肝素相关的机制、益处和风险对于医疗专业人员至关重要。对肝素及其应用的持续教育和意识可以改善患者结果和更安全的医疗实践。